Skip to main content

Table 1 Characteristics of psoriasis patients in present study

From: Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN

Patient Age, years Sex AoO (duration), years PASI Nail involvement PsA Scalp involvement Flexural ininvolvement Treatment
P847 19 M 18 (0.5) 12.5 No No Yes No No
P652 25 M 13 (12) 18.4 Yes No Yes Yes No
P844 27 M 18 (9) 8.8 No No Yes No No
P848 29 M 26 (3) 3.7 No No Yes No No
P840 49 M 15 (34) 6.0 No No Yes Yes Calcipotriol + betamethasone
P845 52 M 22 (30) 14.0 Yes No Yes Yes No
P851 60 M 56 (4) 10.8 No No Yes No No
P853 28 F 28 (0.5) 23.3 No No Yes No No
P849 37 F 30 (7) 4.7 No No No No Topical steroid
P856 54 F 14 (40) 7.3 No Yes Yes Yes Topical steroid
P843 57 F 53 (4) 12.6 No No No No Topical steroid
P846 58 F 57 (1) 15.2 No No Yes No Topical steroid
  1. AoO = Age of Onset, M = male, F = female, PASI = Psoriasis Area and Severity Index, PsA = psoriatic arthritis.